Search

Your search keyword '"Jane Davies"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Jane Davies" Remove constraint Author: "Jane Davies" Topic medicine Remove constraint Topic: medicine
107 results on '"Jane Davies"'

Search Results

1. Engagement and partnership with consumers and communities in the co-design and conduct of Research: Lessons from the INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis (INFERR) clinical trial

2. 'Putting the power back into community': A mixed methods evaluation of a chronic hepatitis B training course for the Aboriginal health workforce of Australia’s Northern Territory

3. Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS-Type 1): protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet in patients with type 1 diabetes and overweight and obesity

4. Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021

5. Probiotics to reduce antibiotic administration in care home residents aged 65 years and older: the PRINCESS RCT

6. Comparison of the airway microbiota in children with chronic suppurative lung disease

7. Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study

8. Data linkage and computerised algorithmic coding to enhance individual clinical care for Aboriginal people living with chronic hepatitis B in the Northern Territory of Australia - Is it feasible?

10. Protocol for a double-blind placebo-controlled trial to evaluate the efficacy of probiotics in reducing antibiotics for infection in care home residents: the Probiotics to Reduce Infections iN CarE home reSidentS (PRINCESS) trial

11. Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population.

12. Disordered microbial communities in asthmatic airways.

13. The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation

14. Evaluating apheresis platelets at reduced dose as a contingency measure for extreme shortages

15. High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study

16. Skin biomechanical properties and leg volume in aging healthy adults

17. A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

18. Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition

20. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

21. INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial

22. Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians

23. The experience of partners supporting adolescents and young adults with cancer

24. 1283 Can online virtual instruction deliver success for RCPCH COVID-adapted clinical examination candidates?... We think so

25. Making every drop count: reducing wastage of a novel blood component for transfusion of trauma patients

26. Viral hepatitis in correctional facilities in the Northern Territory of Australia 2003–2017

27. CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph

28. Probiotics to reduce antibiotic administration in care home residents aged 65 years and older: the PRINCESS RCT

29. Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England

30. Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia

31. Transfusion Strategies in the Pre-Hospital Setting: Evaluating the Logistical Benefits of Pre-Hospital Whole Blood Transfusion, and a National Survey of Pre-Hospital Blood Transfusion

32. Robust and Prototypical Immune Responses Towards Influenza Vaccines in the High-Risk Group of Indigenous Australians

33. 'This Is the First Time I've Talked About This': Considerations When Conducting Qualitative Research Interviews with Adolescents and Young Adults with Cancer

34. Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature

35. Hepatocellular carcinoma in Indigenous Australians: a call to action

36. Diagnostic performance of the faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: a service evaluation in the South West of England

37. Tracing Ancient Human Migrations into Sahul Using Hepatitis B Virus Genomes

38. A 'one stop liver shop' approach improves the cascade-of-care for Aboriginal and Torres Strait Islander Australians living with chronic hepatitis B in the Northern Territory of Australia: results of a novel care delivery model

39. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia

40. Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort

41. Hepatitis B virus and human T-cell lymphotropic virus type 1 co-infection in the Northern Territory, Australia

42. Successful containment to date of <scp>SARS</scp> ‐CoV‐2 transmission in the Northern Territory

43. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial

44. Minimal Compared With Standard Monitoring During Sofosbuvir-Based Hepatitis C Treatment: A Randomized Controlled Trial

45. Conducting a Randomized Controlled Trial in Care Homes: The Challenges of Recruiting Residents Who Lack Capacity to Consent

46. Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort Study

47. Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia

48. Mutations in EXTL3 Cause Neuro-immuno-skeletal Dysplasia Syndrome

49. The authenticity of using visual methods to represent the emotional well-being of children and young people with cerebral palsy

50. The unique aspects of chronic hepatitis B infection in Aboriginal and Torres Strait Islander people

Catalog

Books, media, physical & digital resources